Clinical Trial Update: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

View source ↗

Summary

An update on the Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry indicating the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastic Plasmacytoid Dendritic Cell Neoplasm

Snippet

Sponsor: Immune Oncology Research Institute | Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Status: RECRUITING